Belgium· BE-AMP-SAM002642-00
Hexomedine Oplossing 1 mg/ml
A hexamidine product containing hexamidine diisetionate, registered in Belgium by Melisana.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Hexamidine Diisetionate
- Manufacturer
- Melisana
- Country
- Belgium (BE)
- ATC code
- D08AC04
- ATC class
- Hexamidine
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb0115030
- be_apb0047555
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Hexamidine in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaZAMISEPTLaboratoires Thea, Clermont-Ferrand
- GermanyLaryngomedin NCassella-Med Gmbh & Co. Kg
- FinlandZamiseptLaboratoires Thea
- FranceZAMELINE 1 mg/mL, collyre en solutionTHEA
- SwedenZamisept 1 mg/ml Ögondroppar, lösningLaboratoires THEA
- United StatesPHARMBANNER Anti-Fungal Shampoo.Shenzhen Xinxin Yunhai Technology Co., Ltd.
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Bulgaria · Замидин
- Czechia · Zamisept
- Germany · Laryngomedin N, Zamidine
- Denmark · Zamisept
- Finland · Zamisept
- France · Desomedine, Hexamidine Gilbert
- Greece · Zameline
- Iceland · Zameline
- Italy · Zamidine
- Luxembourg · Desomedine, Hexomedine Lösung
- Norway · Zamisept
- Poland · Zamidine
- Portugal · Zamisept
- Romania · Zamidine
- Sweden · Zamisept
- Slovakia · Zamisept
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8e85489a-d351-4ce1-9ca0-dfc30125ff12 GET /v1/drugs/8e85489a-d351-4ce1-9ca0-dfc30125ff12?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Cutaneous solution",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Hexomedine Oplossing 1 mg/ml",
"name_fr": "Hexomedine Oplossing 1 mg/ml",
"name_nl": "Hexomedine Oplossing 1 mg/ml",
"amp_code": "SAM002642-00",
"strengths": [
"100.0000",
"1.0000"
],
"pack_count": 2,
"substances": [
"Hexamidine Diisetionate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Hexamidine",
"authorisation_numbers": [
"BE002642"
]
}See everything about hexamidine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.